Regeneron (REGN) Reports Libtayo in Combination with Chemotherapy Approved in EU as First-line Treatment of Advanced PD-L1 Positive NSCLC streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.